Skip to main content

News All News

Press Contact: Kirsten Mabry | (617) 495-4157

Tag: Clinical-Trial Stage Company

June 22nd, 2026

Finding ways to ‘drug the undruggable’ diseases

For more than three decades, Greg Verdine has brought bold, innovative methods to solving some of medicine’s biggest challenges - from early-stage work backed by the Harvard Blavatnik Biomedical Accelerator to the launch of multiple startups.

Page 1 of 1